Is HPC Biosciences Ltd debt-free?

Yes, HPC Biosciences Ltd is debt-free with a debt-to-equity ratio of 0.00.

Home

HPC Biosciences Ltd

HPC Biosciences Ltd Financials

HPC Biosciences Ltd Financial Statement

HPC Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2020	Dec 2019	Mar 2017
Revenue	0.85	TBA	1.32
Operating Expense	0.28	TBA	0.41
Net Profit	0.25	TBA	0.40
Net Profit Margin	29.41	TBA	30.30
Earning Per Share	0.02	TBA	0.03
EBIDTA	0.57	TBA	0.91
Effective Tax Rate	3.51	TBA	1.11

Particulars	Mar 2020
Revenue	0.85
Operating Expense	0.28
Net Profit	0.25
Net Profit Margin	29.41
Earning Per Share	0.02
EBIDTA	0.57
Effective Tax Rate	3.51

HPC Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
Total Revenue Annual	2.29	1.20	1.60
Operating Expenses Annual	0.67	0.33	0.40
Operating Profit Annual	1.70	0.97	1.29
Interest Annual	TBA	TBA	TBA
Depreciation	0.51	0.61	0.72
Net Profit Annual	1.17	0.34	0.55
Tax Annual	0.02	0.02	0.02

Particulars	Mar 2021
Total Revenue Annual	2.29
Operating Expenses Annual	0.67
Operating Profit Annual	1.70
Interest Annual	TBA
Depreciation	0.51
Net Profit Annual	1.17
Tax Annual	0.02

HPC Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
Cash Flow at the Beginning	0.30	0.27	0.05
Cash Flow from Operations	1.36	0.82	1.17
Cash Flow from Investing	0.06	-0.79	-0.96
Cash Flow from Financing	TBA	TBA	TBA
Cash Flow at the End	1.72	0.30	0.27

Particulars	Mar 2021
Cash Flow at the Beginning	0.30
Cash Flow from Operations	1.36
Cash Flow from Investing	0.06
Cash Flow from Financing	TBA
Cash Flow at the End	1.72

HPC Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
PBDIT Margin (%)	74.24	80.83	80.63
PBIT Margin (%)	51.97	30	35.63
PBT Margin (%)	51.97	30	35.63
Net PROFIT Margin (%)	51.09	28.33	34.38
Return On Networth / Equity (%)	3.63	1.08	1.77
Return On Networth /Employed (%)	3.69	1.14	1.83
Return On Assets (%)	3.58	1.13	1.72
Total Debt / Equity (X)	TBA	TBA	TBA
Asset Turnover Ratio (%)	0.07	0.04	0.05

Particulars	Mar 2021
PBDIT Margin (%)	74.24
PBIT Margin (%)	51.97
PBT Margin (%)	51.97
Net PROFIT Margin (%)	51.09
Return On Networth / Equity (%)	3.63
Return On Networth /Employed (%)	3.69
Return On Assets (%)	3.58
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.07

HPC Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2021	Mar 2020	Mar 2019
Fixed Assets Annual	3.07	3.58	4.19
Total Current Assets Annual	26.07	24.57	23.72
Non Current Assets Annual	7.06	7.57	8.18
Total Shareholders Funds Annual	32.85	31.68	31.34
Total Assets Annual	33.13	32.14	31.90

Particulars	Mar 2021
Fixed Assets Annual	3.07
Total Current Assets Annual	26.07
Non Current Assets Annual	7.06
Total Shareholders Funds Annual	32.85
Total Assets Annual	33.13

HPC Biosciences Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on HPC Biosciences Ltd Financials

As of Nov 16, 2025, HPC Biosciences Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, HPC Biosciences Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , HPC Biosciences Ltd recorded a total revenue of approximately 0.21 Cr marking a significant milestone in the company's financial performance.

HPC Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and -1.2% annually, respectively..

HPC Biosciences Ltd's current PE ratio is .

HPC Biosciences Ltd's ROCE averaged 0.7% from the FY ending March 2021 to 2023, with a median of 0.1%. It peaked at 3.6% in March 2021, reflecting strong capital efficiency over the period..

HPC Biosciences Ltd's latest EBIT is Rs. 0.03 Cr, surpassing the average EBIT of Rs. 0.25 Cr over the 5 years..